Dr. Daniel Richardo Carrizosa, MD
- Medicare services, 2024
- 615
- Medicare patients, 2024
- 117
- Part D claims, 2024
- 497
- Publications
- 25
- Clinical trials
- 7
- Practice address
- 1000 Blythe Blvd, Charlotte, NC 28203
- Practice phone
- Call (704) 355-2000
- Professional email
- Get professional email
- Personal email
- Get personal email
- Mobile number
- Get mobile number
Primary practice
Find Dr. Carrizosa's professional email, personal email and mobile number
Dmand AI checks each channel through healthcare-specific waterfall enrichment. See what is on file with a free account, with practice phones, licenses and affiliations.
Dr. Daniel Richardo Carrizosa is a medical oncologist in Charlotte, North Carolina
Dr. Carrizosa practices at Atrium Health Carolinas Medical Center in Charlotte, North Carolina, part of Advocate Health.
Dr. Carrizosa's NPI, 1912022716, was assigned on March 20, 2007. Dr. Carrizosa graduated from University of North Carolina at Chapel Hill School of Medicine in 2004. Dr. Carrizosa holds North Carolina license 200400196.
- NPI
- 1912022716NPI Registry (opens in a new tab)
- Medicare PAC ID
- 6305938952
- NPI enumeration date
- March 20, 2007
- NPI status
- Active
- Accepts Medicare assignment
- Yes
- Offers telehealth
- Yes
- Practice phone
- (704) 355-2000
- Professional email
- Get email
- Personal email
- Get email
- Mobile number
- Get number
- Sex
- Male
- Estimated age
- 48
- Medical school graduation
- 2004
Sources: NPPES NPI Registry (CMS); Dmand AI Professional Profile Data; Dmand AI Affiliation Data; and Doctors and Clinicians National Downloadable File (CMS)
Dr. Daniel Richardo Carrizosa practices at Atrium Health Carolinas Medical Center in Charlotte, North Carolina
Dr. Carrizosa's primary practice is Atrium Health Carolinas Medical Center, at 1000 Blythe Blvd, Charlotte, NC 28203 in Mecklenburg County. The practice phone is (704) 355-2000.
- Atrium Health Carolinas Medical Center1000 Blythe Blvd, Charlotte, NC 28203 · Mecklenburg CountyPhone(704) 355-2000
Source: Dmand AI Affiliation Data
Dr. Daniel Richardo Carrizosa is affiliated with 5 sites of care and 1 medical group
Dr. Carrizosa's primary practice is Atrium Health Carolinas Medical Center in Charlotte, North Carolina, part of Advocate Health. Dr. Carrizosa is also affiliated with Novant Health Presbyterian Medical Center. The medical group on file is Atrium Health Levine Cancer Institute. Dmand AI also links Dr. Carrizosa to 2 more hospitals and 1 group practice or clinic, each named with a free account.
Sources: Dmand AI Affiliation Data; and Dmand AI Org Hierarchy Data
Dmand AI tracks the EHR system at Dr. Daniel Richardo Carrizosa's practice
Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Carrizosa practices, 5 sites in all. Vendor and product names are available with a free account.
| Site | EHR vendor and product |
|---|---|
| Atrium Health Carolinas Medical Center | Available with a free account |
| +4 more affiliated sites | Available with a free account |
Source: Dmand AI Technology Install Data
For health IT teams
Dmand AI maps EHR vendors, IT decision makers and buying committees across Advocate Health and 6.2K+ hospitals, with verified contacts in the same login.
Dr. Daniel Richardo Carrizosa is one of 203 medical oncologists in North Carolina
Medical oncology is Dr. Carrizosa's primary specialty in the NPI Registry, under taxonomy code 207RX0202X. Dr. Carrizosa is licensed in North Carolina.
Specialties and state licenses
- Medical oncology, North CarolinaPrimary
Medical oncologists near Dr. Carrizosa
Counts of medical oncologists with a Dmand AI profile, by place and practice. Each opens the list.
Sources: NPPES NPI Registry (CMS); Dmand AI Professional Profile Data; and Dmand AI Peer Benchmarks
Dr. Daniel Richardo Carrizosa billed Medicare for 615 services in 2024
CMS data shows 615 Medicare services from Dr. Carrizosa across 5 procedure codes in 2024, for 117 Medicare patients. Medicare paid $37,242 for them. Every service was in a facility, such as a hospital, rather than an office.
Dr. Carrizosa's Medicare services by type, 2023 to 2024
- 2023
- 2024
- Office and hospital visits
- 2023: 3262024: 3507%
- Other services
- 2023: 312024: 265755%
Dr. Carrizosa compared with the North Carolina median for medical oncologists, 2024
- Dr. Carrizosa
- North Carolina median
- Medicare services
- 615vs 52517% above
- Medicare patients
- 117vs 16630% below
- Part D claims
- 251vs 36732% below
Medians across 199 medical oncologists in North Carolina with Dmand AI profiles that report each measure.
Dr. Carrizosa's most billed Medicare procedure codes, 2024
CMS publishes codes billed for 11 or more Medicare patients. Each label is the code family; CPT descriptions are licensed by the AMA.
Need commercial claims for Dr. Carrizosa?
Medicare shows one payer. Book a meeting to get commercial claims data for Dr. Carrizosa and other medical oncologists in North Carolina.
Sources: Medicare Physician & Other Practitioners - by Provider and Service (CMS), 2024 data; and Dmand AI Peer Benchmarks
Dr. Daniel Richardo Carrizosa treated 117 Medicare patients in 2024, average age 73
CMS counts 117 Medicare patients who saw Dr. Carrizosa in 2024. The largest group is 65 to 74, with 53 patients. 75% of them have high blood pressure, and 70% have high cholesterol. 11% are also on Medicaid. Their average risk score is 2.49, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.
Across all payers, Dmand AI patient panel data puts Dr. Carrizosa's median patient age at 73, with 47% women.
Dr. Carrizosa's Medicare patients by age, 2024
CMS leaves out age groups with fewer than 11 patients.
Dr. Carrizosa's Medicare patients by sex, 2024
- Women5144%
- Men6656%
Chronic conditions among Dr. Carrizosa's Medicare patients, 2024
- High blood pressure75%
- High cholesterol70%
- Cancer46%
- Arthritis35%
- Ischemic heart disease33%
- Diabetes31%
- Atrial fibrillation28%
- COPD28%
Share of Medicare patients with each condition. A patient can have several.
Dr. Carrizosa's patients across all payers
Dmand AI patient panel data covers Medicare, Medicaid and commercial patients.
Patient panel by age, all payers
Median age 73
Patient panel by sex, all payers
- Women47%
- Men53%
Sources: Dmand AI Patient Panel Data; and Medicare Physician & Other Practitioners - by Provider (CMS), 2024 data
Dr. Daniel Richardo Carrizosa wrote 497 Medicare Part D claims in 2024
In 2024, Dr. Carrizosa wrote 497 Medicare Part D claims for 75 patients. 77% of them were for generic drugs. CMS names the drug for 251 of them, across 16 drugs with 11 or more claims each, at $738,055 in total drug cost. In 2023, CMS named 248 claims across 17 drugs.
Dr. Carrizosa's Part D claims by kind of drug, 2024
- Generic381 claims77%
- Brand-name and other116 claims23%
Dr. Carrizosa's most prescribed drugs by claims, 2024
CMS names a drug when it has 11 or more claims. Share is of the claims for drugs CMS names.
Drug classes CMS tracks in Dr. Carrizosa's Part D claims, 2024
- Opioids7%35 of 497 claims
- Antibiotics4%21 of 497 claims
- Antipsychotics, patients 65 and over4%20 of 497 claims
Share of all Part D claims for each drug class CMS reports on. Classes with no claims are left out.
Part D claims for drugs CMS names, 2023 to 2024
- 2023
- 2024
- Claims for drugs CMS names
- 2023: 2482024: 2511%
Drugs named by CMS: 16 in 2024, 17 in 2023.
Sources: Medicare Part D Prescribers - by Provider and Drug (CMS), 2024 data, released May 6, 2026; and Medicare Part D Prescribers - by Provider (CMS), 2024 data
Dr. Daniel Richardo Carrizosa scored 100 out of 100 in Medicare's MIPS program for 2024
CMS publishes a Merit-based Incentive Payment System (MIPS) score of 100 out of 100 for Dr. Carrizosa for performance year 2024, reported as part of a group. Dr. Carrizosa accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Carrizosa as offering telehealth.
- Accepts Medicare assignment
- Yes
- Offers telehealth
- Yes
Dr. Carrizosa's MIPS scores, performance year 2024
- 100of 100Final score
- 99of 100Promoting Interoperability
- 40of 100Improvement Activities
Each score is out of 100. The final score weighs the categories CMS scored for this clinician.
Sources: Doctors and Clinicians National Downloadable File (CMS); and Clinician Public Reporting: Overall MIPS Performance (CMS), 2024 data, released September 10, 2026
For MedTech and pharma teams
Filter 7.4M+ HCPs by Medicare procedures, Part D drugs and Open Payments history, then reach them with verified contacts in one login.
Dr. Daniel Richardo Carrizosa has 25 publications on record
Dmand AI links 25 papers to Dr. Carrizosa, published from 2014 to 2025. 2024 was the busiest year, with 5. The most frequent topics are Head and Neck Neoplasms, Lung Neoplasms and Antineoplastic Agents, Hormonal. Dr. Carrizosa has published most often in JCO Oncol Pract. Dr. Carrizosa's most frequent co-authors are Matthew Christopher Ward, MD, Daniel Scott Brickman and Zvonimir Luka Milas, MD.
Dr. Carrizosa's papers by year, 2015 to 2025
Topics Dr. Carrizosa writes about most
- Head and Neck Neoplasms
- Lung Neoplasms
- Antineoplastic Agents, Hormonal
- Cytochrome P-450 CYP2D6
- Genotype
- Medical Oncology
- Oropharyngeal Neoplasms
- Papillomavirus Infections
Dr. Carrizosa's most frequent co-authors
- Matthew Christopher Ward, MD9 shared papers
- Daniel Scott Brickman8 shared papers
- Zvonimir Luka Milas, MD8 shared papers
Recent publications by Dr. Carrizosa
See who Dr. Carrizosa researches with
Physician Network Discovery turns co-authorship, shared hospitals and shared groups into a map of who Dr. Carrizosa works with, so you can find a warm path to the right medical oncologists.
Sources: PubMed (National Library of Medicine); and Dmand AI Research Linkage
Dr. Daniel Richardo Carrizosa has worked on 7 clinical trials
Dmand AI links Dr. Carrizosa to 7 clinical trials, 3 of them phase 3 studies. 5 are still active or recruiting. Conditions studied include Carcinoma, Non-Small-Cell Lung, Lung Neoplasms and Carcinoma, Bronchogenic. National Cancer Institute (NCI) sponsors the most, 4.
Clinical trials with Dr. Carrizosa by phase
- NonePhase 1: no trials
- 1Phase 1/2: 1 trial
- 2Phase 2: 2 trials
- 1Phase 2/3: 1 trial
- 3Phase 3: 3 trials
- NonePhase 4: no trials
Conditions in Dr. Carrizosa's trials
- Carcinoma, Non-Small-Cell Lung
- Lung Neoplasms
- Carcinoma, Bronchogenic
- Thoracic Neoplasms
- Head and Neck Neoplasms
Investigators on the most trials with Dr. Carrizosa
- Timothy Hancock Dorius, MD3 shared trials
- Neal Dunlap, MD3 shared trials
- Harish Gangaram Ahuja, MD2 shared trials
Recent clinical trials with Dr. Carrizosa
Maintenance Systemic Therapy Versus Local Consolidative Therapy (LCT) Plus Maintenance Systemic Therapy for Limited Metastatic Non-Small Cell Lung Cancer (NSCLC): A Randomized Phase II/III Trial (opens in a new tab)
A Phase 1/2 Study of the Safety, Pharmacokinetics, and Anti-Tumor Activity of the Oral EGFR/HER2 Inhibitor TAK-788 (AP32788) in Non-Small Cell Lung Cancer (opens in a new tab)
Testing Maintenance Therapy for Small Cell Lung Cancer in Patients With SLFN11 Positive Biomarker (opens in a new tab)
Testing the Addition of a New Immunotherapy Drug, Atezolizumab (MPDL3280A), to the Usual Chemoradiation (CRT) Therapy Treatment for Limited Stage Small Cell Lung Cancer (LS-SCLC) (opens in a new tab)
Sources: Dmand AI Research Linkage; and ClinicalTrials.gov (National Library of Medicine)
Dr. Daniel Richardo Carrizosa received $23,655 in industry payments from 2016 to 2025
CMS Open Payments shows 47 general payments to Dr. Carrizosa from 14 drug and device companies from 2016 to 2025. Consulting fees make up the largest share, 50% of the total. Bristol-Myers Squibb Company paid the most, $8,445. It also lists 5 research payments totaling $1,634 from 2016 to 2019.
General payments to Dr. Carrizosa by program year, 2016 to 2025
General payments to Dr. Carrizosa by kind, 2016 to 2025
- Consulting fees$11,75250%
- Speaker and faculty fees$8,49936%
- Food and beverage$2,1509%
- Travel and lodging$1,2545%
Companies that paid Dr. Carrizosa the most, 2016 to 2025
Share is of all general payments to this clinician.
Source: Open Payments (CMS), 2025 data, released July 7, 2026
Dr. Daniel Richardo Carrizosa graduated from University of North Carolina at Chapel Hill School of Medicine
Dr. Carrizosa graduated from University of North Carolina at Chapel Hill School of Medicine in 2004.
- Medical school
Source: Dmand AI Professional Profile Data
Sources for Dr. Daniel Richardo Carrizosa's profile data
| Data on this page | Source |
|---|---|
| NPI, name, sex, specialty and licenses | NPPES NPI Registry (CMS) (opens in a new tab)Dmand AI Professional Profile Data |
| Practice locations and phone | Dmand AI Affiliation Data |
| Primary practice, affiliations and health system | Dmand AI Affiliation DataDmand AI Org Hierarchy Data |
| Medicare services and procedure codes | Medicare Physician & Other Practitioners - by Provider and Service (CMS) (opens in a new tab) |
| State medians for the same specialty | Dmand AI Peer Benchmarks |
| Medicare patients and the all-payer patient panel | Dmand AI Patient Panel DataMedicare Physician & Other Practitioners - by Provider (CMS) (opens in a new tab) |
| Part D prescribing | Medicare Part D Prescribers - by Provider and Drug (CMS) (opens in a new tab)Medicare Part D Prescribers - by Provider (CMS) (opens in a new tab) |
| MIPS scores, telehealth, assignment and procedure percentiles | Doctors and Clinicians National Downloadable File (CMS) (opens in a new tab)Clinician Public Reporting: Overall MIPS Performance (CMS) (opens in a new tab) |
| Publications, topics and co-authors | PubMed (National Library of Medicine) (opens in a new tab)Dmand AI Research Linkage |
| Clinical trials and co-investigators | Dmand AI Research LinkageClinicalTrials.gov (National Library of Medicine) (opens in a new tab) |
| Industry payments | Open Payments (CMS) (opens in a new tab) |
| Training, board certification and memberships | Dmand AI Professional Profile Data |
| EHR at each practice site | Dmand AI Technology Install Data |
| Similar physicians | Dmand AI Affiliation Data |
Data last refreshed October 2026Report an inaccuracyRemove my information
FAQ
Frequently asked questions about Dr. Daniel Richardo Carrizosa
Spotted something out of date? Email hello@dmand.ai and we will check the record. Contact details live in the free trial.
What is Dr. Daniel Richardo Carrizosa's NPI number?
Dr. Daniel Richardo Carrizosa's NPI number is 1912022716. It was assigned on March 20, 2007, and it is active in the NPI Registry.
What kind of doctor is Dr. Daniel Richardo Carrizosa?
Dr. Daniel Richardo Carrizosa is a medical oncologist in Charlotte, North Carolina. The primary specialty in the NPI Registry is Medical Oncology Physician (taxonomy code 207RX0202X).
Where does Dr. Daniel Richardo Carrizosa practice?
Dr. Carrizosa practices at 1000 Blythe Blvd, Charlotte, NC 28203. Dr. Carrizosa's primary practice is Atrium Health Carolinas Medical Center in Charlotte, North Carolina, part of Advocate Health. Dmand AI also links Dr. Carrizosa to 2 hospitals and 1 group practice or clinic.
What is Dr. Daniel Richardo Carrizosa's office phone number?
The practice phone on file for Dr. Carrizosa is (704) 355-2000.
What is Dr. Daniel Richardo Carrizosa's medical license number?
Dr. Carrizosa holds North Carolina license 200400196.
Which hospitals is Dr. Daniel Richardo Carrizosa affiliated with?
Dr. Carrizosa practices at Atrium Health Carolinas Medical Center in Charlotte, North Carolina. Dr. Carrizosa is also affiliated with Novant Health Presbyterian Medical Center. Dmand AI links Dr. Carrizosa to 2 more hospitals.
What medical group is Dr. Daniel Richardo Carrizosa part of?
Dr. Carrizosa is linked to Atrium Health Levine Cancer Institute.
Does Dr. Daniel Richardo Carrizosa accept Medicare?
Yes. CMS data shows Dr. Carrizosa billed Medicare for 615 services in 2024, and Dr. Carrizosa accepts Medicare assignment.
Does Dr. Daniel Richardo Carrizosa offer telehealth?
Yes. The CMS Doctors and Clinicians file lists Dr. Carrizosa as offering telehealth services.
What is Dr. Daniel Richardo Carrizosa's MIPS score?
Dr. Carrizosa's MIPS final score for performance year 2024 is 100 out of 100, reported as part of a group.
Show 8 more questionsShow fewer questions
How many Medicare patients does Dr. Daniel Richardo Carrizosa see?
CMS counts 117 Medicare patients who saw Dr. Carrizosa in 2024, with an average age of 73.
What services does Dr. Daniel Richardo Carrizosa bill to Medicare?
In 2024, Dr. Carrizosa's most billed Medicare services were office visit, established patient (99215), medicare service (G2211) and office visit, established patient (99214).
Where did Dr. Daniel Richardo Carrizosa go to medical school?
Dr. Carrizosa graduated from University of North Carolina at Chapel Hill School of Medicine in 2004.
What drugs does Dr. Daniel Richardo Carrizosa prescribe most?
In 2024 Medicare Part D data, Dr. Carrizosa's most prescribed drugs by claims were Levothyroxine Sodium, Olanzapine and Oxycodone HCl.
Has Dr. Daniel Richardo Carrizosa received payments from drug or device companies?
CMS Open Payments shows $23,655 in general payments to Dr. Carrizosa from 14 companies from 2016 to 2025. The largest total came from Bristol-Myers Squibb Company.
How long has Dr. Daniel Richardo Carrizosa been practicing?
Dr. Carrizosa graduated from medical school in 2004, 22 years ago.
Does Dr. Daniel Richardo Carrizosa do research?
Dmand AI links 25 publications to Dr. Carrizosa, published from 2014 to 2025. Dr. Carrizosa has worked on 7 clinical trials.
Who does Dr. Daniel Richardo Carrizosa publish with?
Dr. Carrizosa's most frequent co-authors are Matthew Christopher Ward, MD (9 shared papers), Daniel Scott Brickman (8 shared papers) and Zvonimir Luka Milas, MD (8 shared papers).
Selling to medical oncology practices?
See medical oncologists in North Carolina by site of care and group
Find the practices, groups and hospitals they work with, and the right people to contact at each.
- 30 days free
- Self-serve
- No credit card